Prevalencia y significado clínico de la infección crónica por el virus de la hepatitis C en las enfermedades autoinmunes sistémicas

Medicina Clinica

Volumn 116, Issue 18, 2001, Pages 701-709

  Ramos Casals, Manuel ^a   Font, Josep ^a   Ingelmo, Miguel ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; HEPATITIS C; HUMAN; MYOSITIS; POLYARTERITIS NODOSA; PREVALENCE; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; HEPATITIS C, CHRONIC; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOSITIS; POLYARTERITIS NODOSA; PREVALENCE; SJOGREN'S SYNDROME;

EID: 0035912633     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(01)71958-6     Document Type: Review

References (181)

1. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-570.
2. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMI-VIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000; 79: 47-56.
3. Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat J et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998; 28: 107-113.
4. Rivera J, Garcia-Monforte A, Pineda A, Millán J. Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol 1999; 26: 420-424.
5. Daniels T, Fox PC. Salivary and cral components of Sjögren's syndrome. Rheum Clin Dis North Am 1992; 18: 571-589.
6. Garcia-Carrasco M, Ramos-Casals M, Cervera R. Sindrome de Sjögren. En: Rojas-Rodriguez J, Garcia-Carrasco M, Cervera R, Font J editores. Enfermedades autoinmunes sistémicas y reumáticas. Barcelona: Ediciones Doyma, 1997; 99-105.
7. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Muñoz FJ et al. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997; 15: 361.
8. Font J, Ramos-Casals M, Cervera R, Bosch X, Mirapeix E, Garcia-Carrasco M et al. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. Br J Rheumatol 1998; 37: 1287-1291.
9. Ramos-Casals M, Cervera R, Garcia-Carrasco M, Miret C, Muñoz FJ, Espinosa G et al. Sindrome de Sjögren primario: caracteristicas clinicas e inmunológicas en una serie de 80 pacientes. Med Clin (Barc) 1997; 108; 652-657.
10. Garcia-Carrasco M, Ramos-Casals M, Cervera R, Font J. Sindrome de Sjögren primario y linfoproliferación. Med Clin (Barc) 2000; 114: 740-746.
11. Ramos-Casals M, Cervera R, Font J, Garcia-Carrasco M, Espinosa G, Reino S et al. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics. Lupus 1998; 7: 202-206.
12. García-Carrasco M, Cervera R, Rosas J, Ramos-Casals M, Morlà RM, Sisó A et al. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lupus 1998; 8: 20-23.
13. Cervera R, Font J, Ramos-Casals M, Garcia-Carrasco M, Rosas J, Morlà RM et al. Primary Sjögren's syndrome in men: clinical and immunological characteristics. Lupus 2000; 9: 61-64.
14. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Font J. Virus y sindrome de Sjögren. Rev Esp Reumatol 1999; 26: 310-317.
15. Mariette X. Sjögren's syndrome: relations avec les infections virales. Presse Med 1993; 22: 569-571.
16. Moutsopoulos H, Papadopoulos G, Youinou P. Le syndrome de Gougerot-Sjögren: les virus au banc des accusés. Ann Med Interne 1994; 145: 25-31.
17. Vidal E, Ranger S, Loustaud V, Verdier M, Liozon F, Denis F. Suspected multiviral involvement in primary Sjögren's syndrome. Clin Exp Rheumatol 1994; 12: 227.
18. Ramos-Casals M, Cervera R, Garcia-Carrasco M, Vidal J, Trejo O, Jiménez S et al. Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome. Semin Arthritis Rheum 2000; 29: 373-378.
19. Font J, Tàssies D, Garcia-Carrasco M, Ramos-Casals M, Cervera R, Reverter JC et al. Hepatitis G virus infection in primary Sjögren's syndrome: analysis in a series of 100 patients. Ann Rheum Dis 1998, 57: 42-44
20. Coll J, Palazón J, Yazbeck H, Gutiérrez J, Aubo C, Benito P et al. Antibodies to human immunodificiency virus (HIV-1) in autoimmune diseases: primary Sjögren's syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases. Clin Rheumatol 1995; 14: 451-457.
21. Maitland N, Flint S, Scully C, Crean SJ. Detection of cytomegalovirus and Epstein-Barr virus in labial salivary glands in Sjogren's syndrome and non-specific sialadenitis. J Oral Pathol Med 1995; 24: 293-298.
22. Garry RF. New evidence for involvement of retroviruses in Sjögren's syndrome and other autoimmune diseases. Arthritis Rheum 1994; 37: 465-469
23. Haddad J, Deny P, Munz-Gotheil C, Ambrosini JC, Trinchet JC, Pateron D et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.
24. Koike K, Moriya K, Ishibashi K, Yotsuyanagi H, Shintani Y, Fujie H et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997; 94: 233-236.
25. Aceti A, Taliani G, Sorice M, Amendolea MA. Hepatitis C virus and Sjögren's syndrome. Lancet 1992; 339: 1425-1426.
26. Chami H, Euller-Ziegler L, Grisot C, Tran A, Breuil V, Brocq O et al. Sjögren's syndrome in patients with hepatitis C virus infection. Arthritis Rheum 1997; 40: S205.
27. Frisoni M, Baffoni L, Miniero R, Boni P, Falasconi C, Ferri S. Virus de l'hepatite C et syndrome de Sjögren: quel lien? Presse Med 1994; 23: 1272.
28. Mariette, Zerbib M, Jaccard AX, Schenmetzler C, Danon F, Clauvel JP. Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum 1993; 36: 280-281.
29. Marson P, Ostuni PA, Vicarioto M, Ongaro G, Gambari PF. Antihepatitis C virus serology in primary Sjögren's syndrome: no evidence of cross-reactivity between rheumatoid factor and specific viral proteins. Clin Exp Rheum 1991; 6: 661
30. Boscagli A, Hatron PY, Canva-Delcambre V, Hachulla E, Janin A, Paris C et al. Syndrome sec et infection par le virus C de l'hépatite: un pseudosyndrome de Gougerot-Sjogren? Rev Med Interne 1996; 17: 375-380.
31. Coll J, Gambus G, Corominas J, Tomás S, Esteban JI, Guardia J. Immunochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus. Ann Rheum Dis 1997; 56: 390-392.
32. De Bandt M. Rôle du virus de l'hépatite C dans les cryoglobulinémies mixtes «essentielles» et le syndrome de Gougerot-Sjögren. Presse Med 1992; 21: 1750-1752.
33. Fernández-Campillo J, Martín-Mola E, Martinez-Zapico J, Gijón-Baños J. Sindrome de Sjögren asociado a infección por virus de hepatitis C: prevalencia y características clinicas. Rev Esp Reumatol 1997; 24: 150.
34. Freni MA, Artuso D, Gerken G, Spanti C, Manafioti T, Alessi N et al. Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology 1995; 22: 389-394.
35. Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C et al. Sicca syndrome associated with hepatitis C virus infection. Arthitis Rheum 1996; 39: 1166-1171.
36. Kaplan G. Hepatite virale, VHC et syndrome de Gougerot-Sjogren. L'Actualité Rhumatologique 1993. Paris: Expansion Scientifique Française, 1993; 11-18.
37. Loustaud-Ratti V, Riche A, Nicot T. Le syndrome sec au cours des hépatites chroniques C n'est pas lié au génotype mais à l'activité histologique hépatique. Rev Med Interne 1995; 16: 390S.
38. Loustaud-Ratti V, Vidal E., Delaire L. Gougerot-Sjögren, syndrome sec et hépatite C. Rev Med Interne 1992; 13: S346.
39. Perney P, Jorgensen C, Legouffe MC. Syndrome de Gougerot-Sjögren et Infection virale C: caracteristiques cliniques, immunologiques, génétiques et génotypiques. Rev Med Interne 1995; 16 (Supl 3): 390.
40. Perrot S, Job-Deslandre C, Puechal X. Sjögren's syndrome or systemic disease due to hepatitis C virus? Lupus 1995; 4 (Supl): 88.
41. Poet JL, Garnier PP, Tonolli-Serabian I, Mattei JP, Gauthier A, Roux H. Hépatite chronique C et syndrome de Gougerot-Sjögren. Rev Rhum 1993; 60: 305-307.
42. Garcia-Carrasco M, Ramos-Casals M, Cervera R, Font J, Vidal J, Muñoz FJ et al. Hepatitis C virus infection in «primary» Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997; 56: 173-175.
43. Scott CA, Avellini C, Desinan L, Pirisi M, Ferraccioli GF, Bardus P et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Histopathology 1997; 30: 41-48.
44. Wattiaux MJ, Jouan-Flahault C, Youinou P, Cabane J, Andreani T, Serfaty L et al. Association of Gougerot-Sjögren syndrome and viral hepatitis C. Apropos of 6 cases. Ann Med Interne (Paris) 1995; 146: 247-250.
45. Lobreglio G, Salerno L, Ciullo A. SSA/SSB autoantibodies in patients with chronic hepatitis C virus liver disease [resumen]. J Hepatol 1993; 17 (Supl): 32.
46. Marrone A, Di Bisceglie AM, Fox P. Absence of hepatitis C viral infection among patients with primary Sjögren's syndrome. J Hepatol 1995; 22: 599.
47. Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Manthorpe R et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245: 127-132.
48. Vitali C, Sciuto M, Neri R, Greco F, Mavridis AR, Tzioufas AG et al. Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hypergammaglobulinaemia. Clin Exp Rheumatol 1992; 10: 103-104.
49. Wattiaux MJ, Fiahault CJ, Serfaty L, Andreani T, Cabane J, Imbert JC, Hepatitis C virus infection associated with Sjögren's syndrome. Arthritis Rheum 1995; 38 (Supl): 377.
50. Pirisi M, Scott C, Fabris C, Ferraccioli G, Soardo G, Ricci R. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 1994; 29: 940-942.
51. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E et al. Association between hepatitis C virus and mixed cryoglobulinemia. Arthritis Rheum 1991; 6: 621-624.
52. Barrier JH, Magadur-Joly G, Gassin M. Le VHC: un agent étiologique improbable du SGS. Presse Medicale 1993; 22: 1108.
53. Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Sjögren's syndrome and hepatitis C virus. Clin Rheumatol 1999; 18: 93-100.
54. King PD, Mcmurray RW, Becherer PR. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994; 89: 1047-1059.
55. Gordon SC. Extrahepatic manifestations of hepatitis C. Dig Dis 1996; 14: 157-168.
56. Selva-O'Callaghan A, Rodríguez-Pardo D, Sánchez-Sitjes L, Matas-Pericas L, Solans-Laque R, Bosch-Gil JA et al. Hepatitis C virus infection Sjogren's syndrome, and non-Hodgkin's lymphoma. Arthritis Rheum 1999; 42: 2489-2490.
57. Garcia-Carrasco M, Ramos-Casals M, Cervera R, Font J. Sindrome de Sjögren e infección por el virus de la hepatitis C. Rev Esp Reumatol 1997; 24: 220-225.
58. Masaki N, Hayashi S. Autoimmune liver disease complicating Sjögren's syndrome. Nippon Rinsho 1995; 10: 2530-2535.
59. Drucker Y. Hepatitis C virus infection in patients with Sjogren's syndrome and non-Hodgkin's limphoma. Arthritis Rheum 2000; 43: 1187.
60. Arrieta JJ, Rodriguez-Íñigo E, Ortiz Movilla N, Bartolomé J, Pardo M, Manzarbeitia F et al. In situ detection of hepatitis C virus RNA in salivary glands. Am J Pathol 2001; 158: 259-264.
61. Ramos-Casals M, Garcia-Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G et al. Hepatitis C virus infection mimicking primary Sjögren's syndrome. Clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8.
62. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al. Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 1993; 36: 340-347.
63. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al. Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 1996; 55: 116-121.
64. Rivera J, Garcia-Monforte A, Millan J. Extrahepatic symtoms as presenting manifestations of hepatitis C virus infection. J Clin Rheumatol 1999; 5: 268-272.
65. Romero M, De Diego A, Rivera J, Garcia-Monforte A, Piqueras B, Garcia F et al. Rheumatologic and autoimmune manifestations in patients with chronic hepatitis C virus infection. Rev Esp Enferm Digest 1997; 89: 591-598.
66. Poet JL, Tonelli-Serabian Y, Garnier PP. Chronic hepatitis C and Sjögren's syndrome. J Rheumatol 1994; 21: 1376-1377.
67. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-848.
68. Almasio A, Provenzano G, Scimeni M, Cascio G, Craxi A, Pagliaro L. Hepatitis C virus and Sjögren's syndrome. Lancet 1992; 339: 989-990.
69. Guisset M, Klotz F, Debonne JM, Vitte S. Syndrome sec et hépatite virale chronique C de bas grade. A propos d'une série de 50 cas. Ann Med Interne 1993; 14: 1006.
70. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C et al. Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173.
71. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26: 561-566.
72. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunological features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108: 157-164.
73. Saracco G, Touscoz A, Durazzo M, Rosina F, Donegani E, Chiandussi L et al. Autoantibodies and response to interferon in patients with chronic viral hepatitis. J Hepatol 1990; 11: 339-343.
74. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Taswell HF, Homburger HA et al. Evidence against hepatitis viruses as important causes of severe auto-immune hepatitis in the United states. J Hepatol 1993; 18: 342-352.
75. Fried MW, Draguesku JO, Shindo M, Simpson LH, Banks SM, Hoofnagle JH et al. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 1993; 38: 631-636.
76. Reddy KR, Krawitt EL, Radick B. Absence of LKM 1 antibody in hepatitis C viral infection in the United states. Hepatology 1993; 18: 173A.
77. Krawitt EL, Rakela J. Antinuclear antibodies and antismooth antibodies in hepatitis C virus infection. The 8th triennal Congress International Symposium on viral hepatitis and liver disease. Tokyo: 10-14 marzo 1993; 189.
78. Borotto E, Lunel F, Valla D, Abuaf N, Perrin M, Bousquet JC et al. Prévalence et signification des anticorps antiorganites non spécifiques du foie au cours des hepatitis chroniques virales C. Gastroenterol Clin Biol 1994; 18: 813-818.
79. Rolachon A, Pasquier D, Girard M, Arvieux J, Bichard P, Bensa JC et al. Existe-t-il un lien entre la presence d'auto-anticorps ou d'une cryoglobulinemie mixte et les caracteres cliniques et histologiques de l'hepatite virale chronique C? Gastroenterol Clin Biol 1994; 18: 251-256.
80. McFarlane BM, Bridger C, Tibbs CJ, Saleh MG, Fuzio A, Verucchi G et al. Virus-induced autoimmunity in hepatitis C virus infections: a rare event. J Med Virol 1994; 42: 66-72.
81. Richardet JP, Lons T, Johanet C, Abourached A, Raffoux C, Grimbert S et al. Prevalence et caracteristiques des anticorps anti-tissus au cours des hepatites chroniques dues au virus de l'hepatite C. Gastroenterol Clin Biol 1994; 18: 819-823.
82. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-619.
83. Casato M, Taliani G, Pucillo LP, Goffredo F, Lagane B, Bonomo L. Cryoglobulinemia and hepatitis C virus. Lancet 1991; 337: 1047-1048.
84. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577.
85. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Font J, Ingelmo M. Mixed cryoglobulinemia: new concepts. Lupus 2000; 9: 83-91.
86. Cohen P. Les manifestations extra-hepatiques du virus de l'hépatite C. Presse Med 2000; 29: 209-214.
87. Ramos-Casals M, Cervera R, Trejo O, Garcia-Carrasco M, Yague J, Atzeni F et al. Study of the etiology, clinical manifestations and immunological features of 200 patients with cryoglobulinemia. Arthritis Rheum 1999; 42 (Supl): 212.
88. Ramos-Casals M, García-Carrasco M, Font J, Cervera R, Rosas J, Sánchez-Tapias JM et al. Clinical and immunological characterization of Sjögren's syndrome associated to hepatitis C virus infection. Clin Exp Rheum 2000; 18: 145-146.
89. Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G et al. Hepatitis C virus infection in non-Hodgkin's B cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994; 24: 781-784.
90. Pozzato G, Mazzaro C, Crovatto M, Modolo ML, Ceselli S, Mazzi G et al. Low-grade malignant lymphoma, hepatitis C virus infection and MC. Blood 1994; 84: 3047-3053.
91. Ramos-Casals M, García-Carrasco M, Cervera R, Filella X, Rosas J, Sánchez-Tapias JM et al. A different immunological and cytokine profile of Sjögren's syndrome associated to HCV infection compared with primary Sjögren's syndrome. Gut 2001 (en prensa).
92. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine (Baltimore) 1993; 72: 113-124.
93. Font J, Ramos-Casals M, Cervera R, García-Carrasco M, Torras A, Sisó A et al. The influence of cardiovascular risk factors in the long term outcome of lupus nephritis: a prospective 10-year follow-up study of 70 patients. QJM 2001; 94: 19-26.
94. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. Medicine (Baltimore) 1999; 78: 167-175.
95. Font J, Cervera R, Espinosa G, Pallares L, Ramos M, Jiménez S et al. Systemic lupus erythematosus in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57: 456-459.
96. Font J, Cervera R, Navarro M, Pallarés L, López-Soto A, Vivancos J et al. Systemic lupus erythematosus in men: clinical and immunological characteristics. Ann Rheum Dis 1992; 51: 1050-1052.
97. Font J, Pallarés L, Cervera R, López-Soto A, Navarro M, Bosch X et al. Systemic lupus erythematosus in the elderly. Ann Rheum Dis 1991; 50: 702-705.
98. George J, Shoenfeld Y. Infections, idiotypes and SLE. Lupus 1995; 4: 333-5.
99. Cacoub P, Lunel F, Huong LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992; 116: 605.
100. Marchesoni A, Battafarano N, Podico M, Tosi S. Hepatitis C virus antibodies and systemic lupus erythematosus. Clin Exp Rheumatol 1995; 13: 267.
101. Kowdley KV, Subler DE, Scheffel J, Moore B, Smith H. Hepatitis C virus antibodies in systemic lupus erythematosus. J Clin Gastroenterol 1997; 25: 437-439.
102. Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D et al. Hepatitis B and C viruses serology in patients with SLE. Lupus 1997; 6: 543-544.
103. Karakoç Y, Dilek K, Gullulu M, Yavuz M, Ersoy A, Akalyn H et al. Prevalence of hepatitis C virus antibody in patients with systemic lupus erythematosus. Ann Rheum Dis 1997; 56: 570-571.
104. Yamabe H, Johnson RJ, Gretch DR, Fukushi K, Osawa H, Miyata M et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995; 6: 220-223.
105. Dalekos GN, Kistis KG, Boumba DS, Voulgari P, Zervou EK, Drosos AA et al. Increased incidence of anticardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenetic link to antiphospholipid syndrome. Eur J Gastroenterol Hepatol 2000; 12: 67-74.
106. Ramos-Casals M, Font J, García-Carrasco M, Cervera R, Jiménez S, Trejo O et al. Hepatitis C virus infection mimicking systemic lupus erythematosus. Study of hepatitis C virus infection in a series of 134 spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43: 2801-2806.
107. Perek J, Mittelman M, Eisbruch A, Djaldetti M. Systemic lupus erythematosus preceded by long-term cryoglobulinemia. Ann Rheum Dis 1984; 43: 339-340.
108. Marvisi M. A case of systemic lupus erythematosus or hepatitis C virus? Chest 1998; 113: 1146.
109. Nepveu K, Libman B. Hepatitis C virus as another possible cause of porphyria cutanea tarda and systemic lupus erythematosus. Arthritis Rheum 1996; 39: 352-354.
110. Lee PK, Abrahams I, Bickers DR. Porphyria cutanea tarda occurring in a patient with renal failure, systemic lupus erythematosus and chronic hepatitis C infection treated with hemodyalisis. Cutis 1999; 64: 237-239.
111. Borisova VV, Krel PE. Systemic lupus erythematosus etiologically due to the hepatitis B and C viruses. Ter Arkh 1992; 64: 92-93.
112. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997; 26: 689-701.
113. Albero MD, Rivera F, Merino E, Gil MT, Jiménez LA, Aranda I et al. Hepatitis C virus infection complicating lupus nephritis. Nephrol Dial Transplant 1996; 11: 1342-1345.
114. Munke H, Stockmann F, Ramadori G. Possible association between Behcet's syndrome and chronic hepatitis C virus infection. N Engl J Med 1995; 332: 400-401.
115. Petty GW, Duffy J, Huston J. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc 1996; 71: 671-678.
116. Safadi R, Ilan Y, Ashur Y, Shouval D. Hepatitis C-associated cryoglobulinemia presenting with pericardial effusion. Am J Gastroenterol 1997; 92: 710-712.
117. Ikeda Y, Nakano H, Sakemi T, Nagano Y, Otsuka N, Baba N et al. A case of membranoproliferative glomerulonephritis due to type II cryoglobulinemia probably associated with hepatitis C virus infection. Nippon Jinzo Gakkai Shi 1994; 36: 284-288.
118. Teragawa H, Hondo T, Amano H, Watanabe H, Ohe H, Hattori N et al. Cardiogenic shock following recombinant alpha-2b interferon therapy for chornic hepatitis C. A case report. Jpn Heart J 1996; 37: 137-142.
119. Rios-Rull P, Rubio M, Ojeda E, Hernández F. Hepatitis-C positive mixed essential cryoglobulinemia, autoimmune hemolytic anemia, and immune thrombocytopenic purpura. Sangre (Barc) 1994; 39: 225.
120. Kazuta Y, Watanabe N, Sagawa K, Kobayashi H, Kojima T, Funabashi H et al. A case of autoimmune hemolytic anemia induced by IFN-beta therapy for type-C chronic hepatitis. Fukushima J Med Sci 1995; 41: 43-49.
121. Katayama T, Naitou Y, Kusaka M, Ochiai S, Yoshida M, Kaito K et al. Autoimmune hemolytic anemia reactivated by alpha-interferon therapy in a case of chronic active C-type hepatitis. Rinsho Ketsueki 1995; 36: 339-346.
122. Hizawa N, Kojima J, Kojima T, Sukoh N, Yamaguchi E, Kawakami Y et al. A patient with chronic hepatitis C who simultaneously developed interstitial pneumonia, hemolytic anemia and cholestatic liver dysfunction after alpha-interferon administration. Intern Med 1994; 33: 337-341.
123. Hirashima N, Mizokami M, Orito E, Yamauchi M, Narita M, Mizuno M et al. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment. Intern Med 1994; 33: 300-302.
124. Bauduer F. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha. Am J Hematol 1996; 53: 209.
125. Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M et al. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-140.
126. Matsuda J, Saitoh N, Gotoh M, Gohchi K, Tsukamoto M, Syoji S et al. High prevalence of APL antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with INF alfa. Am J Gastroenterol 1995; 90: 1138-1141.
127. Leroy V, Arvieux J, Jacob MC, Maynard-Muet M, Baud M, Zarski JP et al. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998; 101: 468-474.
128. Giordano P, Galli M, Del Vecchio GC, Altomare M, Norbis F, Ruggeri L et al. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia. Br J Haematol 1998, 102: 903-906.
129. Mangia A, Margaglione M, Cascavilla I, Gentile R, Cappucci G, Facciorusso D et al. Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol 1999; 94: 2983-2987.
130. Ordi-Ros J, Villarreal J, Monegal F, Sauleda S, Esteban I, Vilardell M. Anticardiolipin antibodies in patients with chronic hepatitis C virus infection: characterization in relation to antiphospholipid sindrome. Clin Diagn Lab Immunol 2000; 7: 241-244.
131. Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199-204.
132. Whelton MJ. Arthropathy and liver disease. Br J Hosp Med 1979; 3: 243-247.
133. Mills PR, Sturrock RD. Clinical associations between arthritis and liver disease. Ann Rheum Dis 1982; 41: 295-307.
134. Borque L, Elena A, Maside C, Rus A, Del Cura J. Rheumatoid arthritis and hepatitis C virus antibodies. Clin Exp Rheumatol 1991; 9: 617-619.
135. Baffoni L, Frisoni M, Miniero R, Righetti F, Sprovieri G, Ferri S et al. True positive anti-HCV tests in rheumatoid arthritis. Br J Rheumatol 1993; 32: 349-350.
136. Vaz Patto J, Peixe P, Parente M, Madeira M, Micaelo A, Teixeira A et al. Treating patients with rheumatoid artritis and hepatitis C: a major problem. Arthritis Rheum 1996; 39 (Supl): 147.
137. Sawada T, Hirohata S, Inoue T, Iko K. Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 1991; 34: 1620-1621.
138. Ueno Y, Kinoshita R, Kishimoto I, Okamoto S. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994; 33: 289-291.
139. Ueno Y, Kinoshita R, Tsujinoue H, Kato M. A case of hepatitis C virus (HCV)-associated arthritis. Quantitative analysis of HCV RNA of the synovial fluid and the serum [letter]. Br J Rheumatol 1995; 34: 691-692.
140. Rivera J, De Diego A, Trinchet M, Garcia Monforte A. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 1997; 36: 981-985.
141. Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979-983.
142. Perrot S, Job-Deslandre C, Puechal X, Menkes CJ. Hepatitis C virus related polyarthritis: 11 cases. Arthritis Rheum 1994; 37 (Supl): 234.
143. Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection. Intern Med 1992; 31: 493-495.
144. Nishikai M, Miyiari M, Kosaka S. Dermatomyositis following infection with hepatitis C virus. J Rheumatol 1994; 21: 1584-1585.
145. Monger RM, West SG. Inflammatory myopathy and hepatitis C virus infection. Arthritis Rheum 1998; 41: 1323-1325.
146. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyo-sitis, pulmonary fibrosis and hepatitis C. Arthritis Rheum 1995; 38: 437-439.
147. Horsman Y, Geubel AP. Symptomatic myopathy in hepatitis C virus infection without interferon therapy. Lancet 1995; 345: 1236.
148. Ueno Y, Kondo K, Kidodoro N, Kobashi R, Kanaji K, Matsumura T et al. Hepatitis C virus infection and polymyositis. Lancet 1995: 346: 319-320.
149. Gómez A, Solans R, Simeón CP, Selva A, Garcia F, Fonollosa V et al. Dermatomyositis, hepatocarcinoma, and hepatitis C. Artritis Rheum 1997; 40: 394-395.
150. Ferri C, La Civita L, Fazzi P, Pasero G, Zignego AL. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C infection. Arthritis Rheum 1996; 39: 1074-1075.
151. Arai H, Tanaka M, Ohta K, Kojo T, Niijima K, Imawari M et al. Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet 1995; 345: 582.
152. Harada M, Sata M, Yoshida H. Inflammatory myopathy associated with hepatitis C virus: a report of 4 cases. Int Hepatol Commun 1995; 4: 195-200.
153. Sergent JS, Lockshin ML, Christian CL, Gocke DJ. Vasculitis with hepatitis B antigenemia. Medicine (Baltimore) 1976; 55: 1-18.
154. Duffy J, Lidsky ML, Sharp JT, Davis JS, Person DA, Hollinger FB et al. Polyarthritis, polyarteritis and hepatitis B. Medicine (Baltimore) 1976; 55: 19-37.
155. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995; 74: 238-253.
156. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20: 304-309.
157. Quint L, Deny P, Guillevin L, Granger B, Jarrousse B, Lhote F et al. Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 1991; 9: 253-257.
158. Deny P, Guillevin L, Bonacorsi S, Quint J. Association between hepatitis C virus and polyarteritis nodosa. Clin Exp Rheumatol 1992; 10: 319.
159. Hortelano Martínez E, Calvo Catalá J, González-Cruz Cervellera MI, Ortega González E, Riera Ayora M, Valero Prieto I et al. Panarteritis nodosa asociada al virus de la hepatitis C. An Med Intern (Madrid) 1997; 14: 241-243.
160. Debat Zoguereh D, Badiaga S, Girard N. Periarterite noueuse revelee par une epilepsie chez un toxicomane porteur des virus de l'hepatite B et C. Rev Med Interne 1997; 18: 311-315.
161. Sautter T, Trinkler FB, Sulser T, Schopke W, Hauri D. Spontaneous perirenal hemorrhage after rupture of an aneurysm in case of polyarteritis nodosa along with anuric renal failure. Case report and review of the literature. Urol Int 1997; 59: 188-190.
162. Galeazzi M, Fioravanti A, Minari C, Selvi E, Veronesi M, Marcolongo R. HLA-B27 positive ankylosing spondylitis and polyarteritis nodosa: a case report. Clin Rheumatol 1996; 15: 204-206.
163. Theilmann L, Blazek M, Goeser T, Gmelin K, Komerel B, Fiehn W. False positive anti-HCV tests in rheumatoid arthritis. Lancet 1990; 336: 1346.
164. Hamuryudan V, Sonsuz A, Yurdakul S. More on hepatitis C virus and Behcet's syndrome. N Engl J Med 1995; 333: 322.
165. Oguz A, Sametoglu F, Erdogan S. More on hepatitis C and Behcet's syndrome. N Engl J Med 1995; 333: 322.
166. Sánchez Roman J, Castillo Palma MJ, Torronteras Santiago R, Núñez Roldan A. Ausencia de relacion entre enfermedad de Behcet e infeccion por virus de la hepatitis B y C. Med Clin (Barc) 1996; 106: 196.
167. Cantini F, Emmi L, Niccoli L, Padula A, Salvarani C, Olivieri I. Lack of association between chronic hepatitis C virus infection and Behcet's disease. Clin Exp Rheumatol 1997; 15: 338-339.
168. Aksu K, Kabasakal Y, Sayiner A, Keser G, Oksel F, Bilgic A et al. Prevalences of hepatitis A, B, C and E viruses in Behcet's disease. Rheumatology (Oxford) 1999; 38: 1279-1281.
169. Ben Ezra D. More on hepatitis C virus and Behcet's syndrome. N Engl J Med 1995; 333: 322..
170. Muñoz-Rodríguez FJ, Tàssies D, Font J, Reverter JC, Cervera R, Sánchez-Tapias JM et al. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 1999; 30: 770-773.
171. Genereau T, Martin A, Lortholary O, Noel V, Guillevin L. Temporal arteritis symptoms in a patient with hepatitis C virus associated type II cryoglobulinemia and small vessel vasculitis. J Rheumatol 1998; 25: 183-185.
172. Ferraccioli GF, Mariuzzi L, Damato R, Rocco M, Pirisi M, Beltrami CA et al. Jaw and leg claudication in a patient with temporal arteritis, chronic sialoadenitis and previous hepatitis C virus infection. Clin Exp Rheumatol 1998; 16: 463-468.
173. Lamprecht P, Schnabel A, Csernok E, Gross WL. ANCA, anti-alpha-enolase antibodies and cryoglobulinemic vasculitis: pathogenetic implications. Clin Exp Rheumatol 1998; 16: 513.
174. Kuniyuki S, Katoh H. Urticarial vasculitis with papular lesions in a patient with type C hepatitis and cryoglobulinemia. J Dermatol 1996; 23: 279-283.
175. Lin RY, Caren CB, Menikoff H. Hypocomplementaemic urticarial vasculitis, interstitial lung disease and hepatitis C. Br J Dermatol 1995; 132: 821-823.
176. Dawson TM, Starkebaum G. Isolated central nervous system vasculitis associated with hepatitis C infection. J Rheumatol 1999; 26: 2273-2276.
177. Garas G, Morgan CA. Hepatitis C and mixed cryoglobulinaemia: a case of primary gastrointestinal necrotising vasculitis. Aust N Z J Med 1996; 26: 110-111.
178. Limaye AP, Schmidt RA, Glenny RW, Davis CL, Kowdley KV. Successful treatment of severe hepatitis C-associated pulmonary vasculitis in a liver transplant recipient. Transplantation 1998; 65: 998-1000.
179. Roithinger FX, Allinger S, Kirchgatterer A, Prischl F, Balon R, Haidenthaler A et al. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to Interferon treatment. Am J Gastroenterol 1995; 90: 1006-1008.
180. Theilmann L, Gmelin K, Kalinowski B, Kommerell B, Koderisch J, Andrassy K et al. Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis. Nephron 1991; 57: 482.
181. Castanet J, Lacour JP, Fuzibet JG, Perrin C, Rodot S, Ortonne JP. Adult Still's disease associated with hepatitis C virus infection. J Am Acad Dermatol 1994; 31: 807-808.